Russia’s first anti-COVID drug registered

The first injectable drug for the treatment of coronavirus infection, Areplivir, has been registered in Russia. By the end of the year, the medicine will begin to arrive in hospitals in Russian regions.

Photo: www.phototass1.cdnvideo.ru

“It will be available in the sale network from the beginning of December. And we will be able to supply it for the whole country, all regions of the country,” said Piotr Bely, the Head of the Promomed Group of Companies.
As the company noted, Promomed was the first in the world to create an injectable form of favipiravir, despite the fact that the substance is an insoluble powder.
As specified by a multicentre clinical trial led by the RAS academician Dmitry Pushkar, the new drug is effective and safe for in-patient use.
According to Sergei Avdeev, the chief pulmonologist of the Russian Ministry of Health and a corresponding member of the Russian Academy of Sciences, the emergence of an effective domestic antiviral drug for parenteral administration can turn the tide in the fight against the pandemic. Until now the only such antiviral drug was a foreign product, expensive and not readily available.

Based on materials of www.gxpnews.net